Sun Young Rha
0000-0002-2512-4531
358 papers found
Refreshing results…
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer
Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy
Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells
Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
Unmet needs in the physical and daily living domain mediates the influence of symptom experience on the quality of life of gastric cancer patients
Development and evaluation of the Cancer Symptom Management System: Symptom Management Improves your LifE (SMILE)—a randomized controlled trial
Missing publications? Search for publications with a matching author name.